Abstract
Vulvar lichen sclerosus (LS) is a chronic vulvar dermatosis potentially impacting quality of life and sexual function. While most women with LS respond to topical corticosteroids and/or calcineurin inhibitors, some require additional therapy. Systemic therapies have been used successfully in oral and vulvovaginal lichen planus with minimal data in the setting of LS. Likewise, while vaginal laser therapy has shown potential benefit for genitourinary syndrome of menopause, there is a paucity of data in the setting of LS. We review retrospective and prospective studies along with randomized controlled trials utilizing vulvovaginal laser for LS therapy.
Original language | English (US) |
---|---|
Pages (from-to) | 768-774 |
Number of pages | 7 |
Journal | Clinical Obstetrics and Gynecology |
Volume | 65 |
Issue number | 4 |
DOIs | |
State | Published - Dec 1 2022 |
Keywords
- corticosteroid
- fractiona laser
- lichen sclerosus
- recalcitrant
ASJC Scopus subject areas
- Obstetrics and Gynecology